Study directory

Mental health studies with practical context.

Compare studies and check their requirements with the research team.

Back to overview

10618studies shown

Showing 8,629-8,640 of 10,618

Drug study icon

CompletedNCT00181935

Risperidone Versus Olanzapine for Mania in Preschool Children 4 to 6 Years of Age With Bipolarity

This summary needs review. Please check the official study record and contact the research team for details.

In United States

BipolarityDrugFrom 4 Years to 6 Years

Countries: United States
Sponsor: Massachusetts General Hospital
Condition: Bipolarity

Behavioral study icon

CompletedNCT02785536

RITCH: Reducing Disparities in Tobacco Cessation Outcomes

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionBehavioralOver 18 Years

Countries: United States
Sponsor: The City College of New York
Condition: Addiction

Drug study icon

CompletedNCT01030692

Rivastigmine and Huperzine A as Treatments for Cocaine Dependence

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionDrugFrom 18 Years to 55 Years

Countries: United States
Sponsor: Baylor College of Medicine
Condition: Addiction

Behavioral study icon

CompletedNCT07592884

Rochester Forensic Assertive Community Treatment Model in Minnesota

This summary needs review. Please check the official study record and contact the research team for details.

In United States

Schizophrenia, BipolarityBehavioralOver 18 Years

Countries: United States
Sponsor: University of Rochester
Condition: Schizophrenia, Bipolarity

Behavioral study icon

TerminatedNCT02505022

Role Functioning Changes NOS

This summary needs review. Please check the official study record and contact the research team for details.

In United States

Schizophrenia, BipolarityBehavioralFrom 18 Years to 26 Years

Countries: United States
Sponsor: Northwestern University
Condition: Schizophrenia, Bipolarity

Device study icon

CompletedNCT03075202

Role of an E-cigarette on Smoking Displacement in Smokers With Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDeviceFrom 21 Years to 65 Years

Countries: United States
Sponsor: Weill Medical College of Cornell University
Condition: Schizophrenia

Drug study icon

Active Not RecruitingNCT04878627

Role of CBD in Regulating Meal Time Anxiety in Eating disorders

This summary needs review. Please check the official study record and contact the research team for details.

In United States

Eating disorders, AnxietyDrugFrom 18 Years to 40 Years

Countries: United States
Sponsor: University of California, San Diego
Condition: Eating disorders, Anxiety

Drug study icon

CompletedNCT00000284

Role of Metabolites in Addiction (1) - 1

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionDrugFrom 21 Years to 45 Years

Countries: United States
Sponsor: National Institute on Drug Abuse (NIDA)
Condition: Addiction

Drug study icon

CompletedNCT00000288

Role of Metabolites in Addiction (2) - 5

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionDrugFrom 21 Years to 45 Years

Countries: United States
Sponsor: National Institute on Drug Abuse (NIDA)
Condition: Addiction

Drug study icon

CompletedNCT00000289

Role of Metabolites in Addiction (3) - 6

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionDrugFrom 21 Years to 45 Years

Countries: United States
Sponsor: National Institute on Drug Abuse (NIDA)
Condition: Addiction

Drug study icon

CompletedNCT00000296

Role of Metabolites in Addiction (4) - 13

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionDrugFrom 21 Years to 45 Years

Countries: United States
Sponsor: National Institute on Drug Abuse (NIDA)
Condition: Addiction

Behavioral study icon

TerminatedNCT05910775

Role Of Non-Specific Effects in The Treatment of Depression With Esketamine

This summary needs review. Please check the official study record and contact the research team for details.

In United States

DepressionBehavioralOver 18 Years

Countries: United States
Sponsor: Yale University
Condition: Depression

Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.